Cancer stem cell gene variants and colon cancer outcome

• Conditions: C18; Malignant neoplasm of colon

• Registration Number: DRKS00004557
• Lead Sponsor: Klinische Abteilung für Onkologie, Medizinische Universität Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-11-21
• Study Completion: 2015-02-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 742

Inclusion Criteria

Colon cancer in stage II and III after curative surgery

Exclusion Criteria

Colon cancer in stage I and IV

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prediction of the time to Tumor recurrence based on the genetic biomarkers

Secondary Outcome Measures

Name	Time	Method
Prediction of overall survival based on the genetic biomarkers